IDIX (MM)

CAMBRIDGE, Mass., Oct. 28 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that management will present a corporate overview at the upcoming Oppenheimer 19th Annual Healthcare Conference on Tuesday, November 4th at 2:00p.m. ET in New York at the Waldorf Astoria and at the Barclays Capital Small & Mid-Cap Healthcare Forum on Thursday, November 6th at 8:30a.m. at Barclays Capital, 745 Seventh Avenue in New York. The live and archived webcasts of the presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com/. Please log in approximately 5-10 minutes before the events to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conferences. About Idenix Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com/. Idenix Pharmaceuticals' Contacts: Media: Teri Dahlman (617) 995-9905 Investors: Amy Sullivan (617) 995-9838 DATASOURCE: Idenix Pharmaceuticals, Inc. CONTACT: Media: Teri Dahlman, +1-617-995-9905, or Investors: Amy Sullivan, +1-617-995-9838, both of Idenix Pharmaceuticals, Inc. Web site: http://www.idenix.com/

Copyright